# Poly(ethylene glycol)-graft-Hyaluronic Acid Hydrogels for Angiogenesis

**Authors:** Miyu Hashimoto, Kazune Oda, Ari Yamamoto, Ik Sung Cho, Yasuhiko Tabata, Masaya Yamamoto, Tooru Ooya

PMC · DOI: 10.3390/polym17212845 · Polymers · 2025-10-24

## TL;DR

This study creates a new type of hydrogel that can slowly release a growth factor to help blood vessels grow, which is useful for tissue repair.

## Contribution

The novel contribution is the development of PEG-grafted hyaluronic acid hydrogels with controlled release of bFGF for angiogenesis.

## Key findings

- PEG60-graft-HA hydrogel showed higher swelling and faster degradation.
- PEG60-graft-HA hydrogel enabled sustained release of bFGF in vitro.
- PEG60-graft-HA significantly promoted angiogenesis in vivo.

## Abstract

Hyaluronic acid (HA) hydrogels are promising biomaterials for tissue engineering and drug delivery due to their biocompatibility and biodegradability. The objective of this study was to develop a novel HA-based hydrogel for the controlled release of basic fibroblast growth factor (bFGF) to promote angiogenesis. A series of PEG-grafted HA hydrogels with varying PEG grafting ratios were synthesized and characterized. We evaluated their physicochemical properties, including swelling ratio, cross-linking density, and enzymatic degradation behavior, and assessed their ability to control bFGF release and induce angiogenesis in a mouse model. The results showed that the PEG-grafting ratio significantly affected the gel properties. Notably, the PEG60-graft-HA hydrogel exhibited a higher swelling ratio and more rapid degradation, suggesting a non-uniform and highly porous structure. In vitro release studies confirmed that while PEG5-graft-HA and PEG15-graft-HA gels showed burst release, the PEG60-graft-HA hydrogel demonstrated sustained release of bFGF over time. Furthermore, in vivo experiments revealed a significant increase in angiogenesis with the PEG60-graft-HA hydrogel, likely due to the prolonged release of active bFGF. These findings suggest that PEG-grafted HA hydrogels, particularly those with a higher PEG grafting ratio, are promising biomaterials for the controlled release of growth factors and applications in tissue regeneration.

## Linked entities

- **Proteins:** FGF2 (fibroblast growth factor 2)
- **Chemicals:** poly(ethylene glycol) (PubChem CID 9033), PEG (PubChem CID 174), HA (PubChem CID 854026)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Fgf2 (fibroblast growth factor 2) [NCBI Gene 14173] {aka Fgf-2, Fgf2a, Fgfb, bFGF}
- **Chemicals:** HA (MESH:D006820), PEG15 (-), PEG (MESH:D011092)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12608165/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12608165/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12608165/full.md

---
Source: https://tomesphere.com/paper/PMC12608165